|17 November 2015|
The fight against cancer got a major boost today with the opening of Piramal Healthcare Limited’s £2 million life science manufacturing hub in Grangemouth.
Officially opened by Scotland’s first minister Nicola Sturgeon the new suite produces antibody drug conjugates which are involved in the treatment of various types of cancer.
The firm received a £200,000 Scottish Enterprise RSA grant towards the building of the facility, which has created 20 high value jobs.
The first minister said: “Piramal is the type of the company we are looking to lead Scotland’s economic growth. They are manufacturing innovative products for international use, and are investing in their workforce and infrastructure – a perfect example of our economic strategy in action.
“Piramal is a great example of an innovative company that is benefitting from the focus Scotland places on the life sciences sector. We have a thriving research and innovation led life sciences sector and Piramal is seeing the benefit of that as they manufacture products that are involved in the treatment of various types of cancer.”
Piramal Healthcare site lead, Mark Wright, said: “Piramal Healthcare UK Ltd has been growing its operations in Grangemouth since 2005 and currently employs around 140 people in predominantly highly skilled positions. We aim to scale up this facility in the next five years to maintain its position as a global leader in the production of Antibody Drug Conjugates.”